RxDoctor Payments DataLook up a doctor →

SYMPAZAN: payments to doctors

Payments that named SYMPAZAN as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$940K
Providers
2,066
Transactions
8,465
Average per transaction
$111

The per-transaction average — $111 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,066 providers the average total is $455, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Aquestive Therapeutics, Inc.$795,72784.6%
Otter Pharmaceuticals, LLC$141,44715.0%
Assertio Therapeutics, Inc.$3,0800.3%
← All drugs & devices